bispecific antibodies

An arrow incrementally going up stairs before pointing straight up Blue background

Biotech

Biokin, having landed BMS deal, posts ph. 3 bispecific ADC win

The phase 3 trial hit at least one primary endpoint, boosting the prospects of a candidate that BMS licensed outside China for $800 million upfront.

Nick Paul Taylor Jul 2, 2025 9:53am

graphic art of a right hand signing something

Sanofi takes up option on Adagene biospecific, invests $25M

Jul 1, 2025 8:10am

Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together

Pfizer CEO makes case for $6B bet on 'fabulous' bispecific

Jun 10, 2025 9:56am

photo of a pair of binoculars perched on a rock aimed at the rising sun

Are Lilly, Novartis eyeing the PD-1xVEGF field? Execs weigh in

Jun 4, 2025 1:00pm

White arrow on a road pointing to the rising sun

J&J shares survival data on KLK2 bispecific in prostate cancer

Jun 2, 2025 6:40am

Businessman climbing steps to pluck a star from the sky

Merus hails 'unprecedented' survival on solid tumor bispecific

May 23, 2025 7:35am